Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients

被引：59
|
作者：
Kerkeni, Mohsen [1 ]
Saidi, Amel [1 ]
Bouzidi, Hassan [2 ]
Letaief, Ahmed [3 ]
Ben Yahia, Salim [4 ]
Hammami, Mohamed [1 ]
机构：
[1] Monastir Univ, Higher Inst Biotechnol, Monastir 5000, Tunisia
[2] CHU Tahar Sfar, Dept Biochem, Mahdia, Tunisia
[3] CHU Fattouma Bouguiba, Dept Neurol, Monastir, Tunisia
[4] CHU Fattouma Bouguiba, Dept Ophthalmol, Monastir, Tunisia
来源：
DIABETES & VASCULAR DISEASE RESEARCH | 2013年 / 10卷 / 03期
关键词：
Advanced glycation end product; soluble receptor for advanced glycation end product; pentosidine; diabetic retinopathy; diabetic nephropathy; GLYCATION END-PRODUCTS; VASCULAR COMPLICATIONS; OXIDATIVE STRESS; PLASMA; AGES; ACCUMULATION; RECEPTOR; DISEASE; PATHOPHYSIOLOGY; INFLAMMATION;
D O I：
10.1177/1479164112460253
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum soluble receptor for advanced glycation end product (sRAGE) may reflect the activity of the advanced glycation end product (AGE)-receptor for advanced glycation end product (RAGE) axis, which has been proposed as a potential mechanism linking hyperglycaemia to vascular complications in diabetes. We have investigated whether serum AGEs, sRAGE and pentosidine levels were increased and correlated with microvascular complications in type 2 diabetes mellitus (DM). We included 30 healthy control subjects, and 200 diabetic patients were divided into two subgroups: 100 patients with diabetic retinopathy and 100 patients with diabetic nephropathy. AGEs, sRAGE and pentosidine were measured in serum by enzyme-linked immunosorbent assay (ELISA). Serum AGEs, sRAGE and pentosidine levels were significantly increased in diabetic patients with retinopathy and in diabetic patients with nephropathy compared to control subjects (p < 0.001). Serum AGEs, sRAGE and pentosidine levels are positively associated with microvascular complications in type 2 DM. Multiple regression analysis reveals serum pentosidine as an independent determinant of the presence of diabetic retinopathy (p = 0.004) and the presence of hypertension (p = 0.018) and hyperlipidaemia (p = 0.036). Pentosidine levels may be a biomarker for microvascular complications in type 2 diabetic patients.
引用
收藏
页码：239 / 245
页数：7
相关论文
共 50 条
  • [21] Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients
    Cardoso, Claudia R. L.
    Ferreira, Marcel T.
    Leite, Nathalie C.
    Barros, Pablo N.
    Conte, Paulo H.
    Salles, Gil F.
    ATHEROSCLEROSIS, 2009, 205 (02) : 472 - 476
  • [22] Increased plasma concentrations of Osteoprotegerin in Type 2 diabetic patients with microvascular complications.
    Knudsen, ST
    Foss, CH
    Poulsen, PL
    Andersen, NH
    Bek, T
    Mogensen, CE
    Rasmussen, LM
    DIABETOLOGIA, 2003, 46 : A397 - A397
  • [23] Intrarenal arterial resistance is associated with microvascular complications in Chinese type 2 diabetic patients
    Liu, Kin Hung
    Chu, Winnie Chiu Wing
    Kong, Alice Pik Shan
    Ko, Gary Tin Choi
    Ma, Ronald Ching Wan
    Chan, Jeff Wai Sang
    So, Wing Yee
    Luk, Andrea O. Y.
    Cheung, Kitty K. T.
    Ozaki, Risa
    Ahuja, Anil T.
    Chan, Juliana Chung Ngor
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (03) : 651 - 658
  • [24] The correlation between transcutaneous oxygen tension and microvascular complications in type 2 diabetic patients
    Huang, Ke
    Ma, Yujin
    Wang, Jie
    Shi, Shousen
    Fu, Liujun
    Liu, Jie
    Li, Liping
    Lu, Haibo
    Liang, Xiaoli
    Liu, Yanyun
    Jiang, Hongwei
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (05) : 886 - 890
  • [25] Serum sialic acid in south Indian type 2 diabetic patients with microvascular complications
    Vijay, V
    Snehalatha, C
    Ramachandran, A
    Jayaraman, M
    DIABETIC MEDICINE, 1998, 15 (02) : 176 - 176
  • [26] Frequency of Macrovascular Complications in Patients With Microvascular Complications and Evaluation of Complication Related Risk Factors Type 2 Diabetic Patients
    Tutuncuoglu, Pelin
    Harman, Ece
    Dolek, Devrim
    Kahya, Nihan
    Bahceci, Mitat
    DIABETES, 2013, 62 : A600 - A601
  • [27] Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications
    Chandni, Radhakrishnan
    Ramamoorthy, Kollengode Parameswaran
    WORLD JOURNAL OF DIABETES, 2012, 3 (05): : 105 - 109
  • [28] Pentosidine: a new biomarker in diabetes mellitus complications
    Morales, Sonia
    Garcia-Salcedo, Jose A.
    Munoz-Torres, Manuel
    MEDICINA CLINICA, 2011, 136 (07): : 298 - 302
  • [29] Cost of hospitalizations due to microvascular and macrovascular complications in type 1 and type 2 diabetic patients in Bulgaria
    Dimitrova, Maria
    Doneva, Miglena
    Valov, Vasil
    Yordanova, Stanislava
    Manova, Manoela
    Savova, Alexandra
    Mitov, Konstantin
    Petrova, Guenka
    Petkova, Valentina
    Czech, Marcin
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2015, 29 (04) : 805 - 813
  • [30] Urinary 8-Hydroxydeoxyguanosine as a Biomarker of Microangiopathic Complications in Type 2 Diabetic Patients
    Amer, Shereen
    CLINICAL BIOCHEMISTRY, 2016, 49 (18)
12345